Related Articles
Gemcitabine resistance in triple‑negative breast cancer cells can be reverted by <em>Drosophila melanogaster</em> deoxyribonucleoside kinase in the nucleus or cytosol
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway
Downregulation of RIP140 in triple‑negative breast cancer inhibits the growth and proliferation of cancer cells
Construction of a tumor‑specific bioluminescent eukaryotic expression vector and analysis of its expression in vitro and in vivo
MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer